Abstract
Purpose
To evaluate the loco-regional recurrence (LRR) rate after breast-conserving surgery without postoperative radiotherapy (RT) for ductal carcinoma in situ (DCIS) of the breast.
Methods
Between 2000 and 2010, 311 DCIS patients from 9 institutions were analyzed retrospectively. The median age was 47 (range, 20–82). The median tumor size was 7 mm (range, 0.01–76). Margin width was <1 cm in 85 patients (27.3%), and nuclear grade was high in 37 patients (11.9%). Two hundred and three patients (65.3%) received tamoxifen.
Results
With a median follow-up of 74 months (range, 5–189), there were 11 local recurrences (invasive carcinoma in 6 and DCIS in 5) and 1 regional recurrence. The 7-year LRR rate was 3.8%. On univariate analysis, age and margin width were significant risk factors influencing LRR (p = 0.017 and 0.014, respectively). When age and margin width were combined among 211 patients whose margin width were available, the 7-year LRR rates were as follows (p < 0.001): (1) 0% in patients with age >50 years and any margin width status (n = 64), (2) 1.2% in age ≤50 years and margin width ≥1 cm (n = 93), (3) 13.1% in age ≤50 years and margin width <1 cm (n = 54).
Conclusions
The LRR rate was very low in selected DCIS patients treated with breast-conserving surgery without postoperative RT. However, adjuvant RT should be considered for those with age ≤50 years and margin width <1 cm.
Similar content being viewed by others
References
Min SY, Kim Z, Hur MH et al (2016) The basic facts of Korean breast cancer in 2013: results of a nationwide survey and breast cancer database. J Breast Cancer 19:1–7
Kang JK, Kim MS, Jang WI et al (2016) The clinical utilization of radiation therapy in Korea between 2009 and 2013. Radiat Oncol J 34:88–95
Warnberg F, Garmo H, Emdin S et al (2014) Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial. J Clin Oncol 32:3613–3618
Donker M, Litiere S, Werutsky G et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059
Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21–29
Fisher B, Dignam J, Wolmark N et al (1988) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: finding from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441–452
Kim H, Noh JM, Choi DH et al (2014) Excision alone for small size ductal carcinoma in situ of the breast. Breast 23:586–590
Lagios MD, Margolin FR, Westdahl PR et al (1989) Mammographically detected ductal carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618–624
Schwartz GF, Finkel GC, Carcia JC et al (1992) Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 70:2468–2474
Hughes LL, Wang M, Page DL et al (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319–5324
McCormick B, Winter K, Hudis C et al (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:709–715
Solin LJ, Gray R, Hughes LL et al (2015) Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol 33:3938–3944
Morrow M, Van Zee KJ, Solin LJ et al (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. J Clin Oncol 34(33):4040–4046
EBCTCG (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 41:162–177
Nixon AJ, Neuberg D, Hayes DF et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888–894
Elkhuizen PHM, van de Vijver MJ, Herman J et al (1998) Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40:859–867
Zhou P, Recht A (2004) Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 101:1264–1274
Tunon-de-Lara C, Andre G, MacGrogan G et al (2011) Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic feature. Retrospective study of 812 patients. Ann Surg Oncol 18:1372–1379
Vicini FA, Shaitelman S, Wilkinson JB et al (2013) Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy. Breast J 19:365–373
Rakovitch E, Nofech-Mozes S, Narod SA et al (2013) Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Res Treat 138:581–590
Moran MS, Schnitt SJ, Giuliano AE et al (2014) Society of Surgical Oncology-American Society of Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys 88:553–564
Van Zee KJ, Subhedar P, Olcese C et al (2015) Relationship between margin width and recurrence of ductal carcinoma in situ. Ann Surg 262:623–631
Wang SY, Chu H, Shamliyan T et al (2012) Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst 104:507–516
Rudloff U, Jacks LM, Goldberg JI et al (2010) Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762–3769
Solin LJ, Gray R, Baehner FL et al (2013) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105:701–710
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Kyubo Kim and So-Youn Jung have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kim, K., Jung, SY., Shin, K.H. et al. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02). Breast Cancer Res Treat 162, 77–83 (2017). https://doi.org/10.1007/s10549-017-4111-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-017-4111-1